MIT researchers, leveraging deep learning technology, have uncovered a breakthrough in combating a drug-resistant bacterium responsible for over 10,000 annual deaths in the United States using antibiotics. Published in Nature, their study reveals a new class of compounds capable of eliminating methicillin-resistant Staphylococcus aureus (MRSA) in laboratory settings and in vivo mouse models. Significantly, these compounds exhibit minimal toxicity towards human cells, positioning them as promising candidates for drug development. The study’s pivotal advancement lies in the researchers’ ability to discern the underlying factors driving the deep-learning model’s antibiotic efficacy predictions. This insight holds promise for the design of enhanced drug therapies surpassing those initially identified by the model.

Read more here.

References

  1. Using AI, MIT researchers identify a new class of antibiotic candidates. (2023, December 20). EurekAlert! https://www.eurekalert.org/news-releases/1029354

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred